These observations are reflected in the rare risk mutations of the Shank gene family that are increased in patients with schizophrenia and ASD compared with healthy controls (HC), underlying some of the cognitive and social dysfunction relevant for both these conditions [10]. This evidence concerns the gene SHANK2 and schizophrenia.